Your browser is no longer supported. Please, upgrade your browser.
Biomerica, Inc.
Index- P/E- EPS (ttm)-0.47 Insider Own11.10% Shs Outstand11.91M Perf Week-12.15%
Market Cap50.02M Forward P/E20.91 EPS next Y0.20 Insider Trans0.00% Shs Float9.67M Perf Month-23.28%
Income-5.50M PEG- EPS next Q-0.08 Inst Own24.90% Short Float10.56% Perf Quarter-47.18%
Sales8.90M P/S5.62 EPS this Y11.40% Inst Trans1.82% Short Ratio8.31 Perf Half Y-30.05%
Book/sh0.89 P/B4.63 EPS next Y140.00% ROA-35.80% Target Price- Perf Year-42.78%
Cash/sh0.44 P/C9.44 EPS next 5Y- ROE-45.10% 52W Range4.20 - 12.75 Perf YTD-17.27%
Dividend- P/FCF- EPS past 5Y-39.30% ROI-17.00% 52W High-67.69% Beta-0.72
Dividend %- Quick Ratio5.90 Sales past 5Y6.20% Gross Margin14.00% 52W Low-1.90% ATR0.33
Employees84 Current Ratio8.00 Sales Q/Q200.00% Oper. Margin-62.80% RSI (14)33.02 Volatility5.33% 6.70%
OptionableYes Debt/Eq0.00 EPS Q/Q-76.10% Profit Margin-61.60% Rel Volume0.63 Prev Close4.40
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume122.93K Price4.12
Recom1.70 SMA20-11.12% SMA50-23.56% SMA200-36.41% Volume79,960 Change-6.36%
Nov-10-20Initiated Colliers Securities Buy $13
Jan-04-18Initiated B. Riley FBR, Inc. Buy $7.50
Apr-20-21 09:35AM  
Apr-15-21 10:31AM  
Apr-07-21 02:33AM  
Feb-17-21 12:23AM  
Jan-15-21 09:27AM  
Jan-13-21 10:26AM  
Jan-12-21 08:19AM  
Jan-03-21 02:06AM  
Dec-16-20 07:05AM  
Dec-09-20 08:19AM  
Oct-16-20 09:27AM  
Oct-05-20 07:16AM  
Sep-01-20 08:19AM  
Aug-31-20 05:00PM  
Aug-25-20 05:51AM  
Aug-21-20 06:31AM  
Aug-13-20 10:26AM  
Aug-12-20 08:19AM  
Aug-05-20 11:15AM  
Jul-22-20 06:39AM  
Jun-29-20 09:39PM  
Jun-16-20 08:19AM  
Jun-06-20 08:01AM  
Jun-01-20 07:38AM  
May-27-20 07:20AM  
May-14-20 06:40AM  
May-07-20 10:27AM  
Apr-15-20 08:30AM  
Apr-03-20 08:28PM  
Apr-02-20 07:38AM  
Apr-01-20 11:43AM  
Mar-30-20 06:22AM  
Mar-19-20 07:37AM  
Mar-18-20 07:36AM  
Mar-17-20 08:16PM  
Feb-26-20 04:41PM  
Feb-13-20 05:15AM  
Jan-15-20 08:19AM  
Jan-09-20 05:45AM  
Jan-07-20 08:19AM  
Dec-04-19 07:00AM  
Oct-29-19 06:43AM  
Oct-16-19 08:19AM  
Sep-29-19 09:15AM  
Sep-19-19 10:15AM  
Aug-30-19 10:31AM  
Aug-21-19 08:19AM  
Jul-25-19 11:33AM  
Jun-19-19 02:28PM  
Jun-05-19 08:19AM  
Apr-25-19 10:06AM  
Apr-22-19 11:00AM  
Apr-16-19 09:18AM  
Apr-08-19 08:19AM  
Mar-12-19 08:45AM  
Feb-21-19 02:49PM  
Feb-05-19 08:19AM  
Jan-22-19 02:42PM  
Jan-21-19 11:00AM  
Jan-15-19 08:19AM  
Nov-28-18 08:19AM  
Nov-16-18 08:55AM  
Nov-07-18 09:42AM  
Oct-22-18 01:15PM  
Oct-16-18 08:30AM  
Sep-26-18 12:00PM  
Sep-07-18 10:00AM  
Aug-30-18 08:19AM  
Aug-02-18 08:19AM  
Jun-25-18 08:19AM  
May-31-18 08:26PM  
May-10-18 05:55PM  
Apr-19-18 09:45AM  
Apr-17-18 03:01PM  
Mar-08-18 08:19AM  
Mar-01-18 06:11PM  
Jan-23-18 09:45AM  
Jan-19-18 10:54AM  
Jan-16-18 09:18AM  
Jan-10-18 08:19AM  
Jan-09-18 08:43AM  
Jan-08-18 08:19AM  
Jan-01-18 06:55PM  
Dec-25-17 11:35AM  
Dec-07-17 04:23PM  
Nov-20-17 08:19AM  
Nov-13-17 05:25PM  
Nov-07-17 08:19AM  
Oct-20-17 11:00AM  
Oct-17-17 08:37AM  
Sep-20-17 09:30AM  
Sep-12-17 08:19AM  
Biomerica, Inc., a biomedical technology company, together with its subsidiaries, develops, patents, manufactures, and markets diagnostic and therapeutic products or detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome (IBS) therapy technology and diagnostic-guided therapy that is designed to allow physicians to identify specific foods that when removed from the patient's diet can alleviate the patient's IBS symptoms; Helicobacter pylori products; and develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coste CatherineDirectorOct 26Buy5.459,10049,5959,100Oct 27 06:34 PM